CapsoVision, Inc. (CV) Financials

CV Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 18.6 million 5.4 million
March 31, 2026 25.9 million 5.7 million
Dec. 31, 2025 18.2 million 4.9 million
Sept. 30, 2025 25.7 million 5.2 million

CV Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -8.4 million 577000
March 31, 2026 -6.1 million 334000
Dec. 31, 2025 -7.7 million 197000
Sept. 30, 2025 -5.7 million 307000

CV Net Income

No data available :(

CV Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 9.1 million - -
March 31, 2026 17.9 million - 788000
Dec. 31, 2025 10.1 million - 887000
Sept. 30, 2025 17.8 million - 978000

CV Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 49.9 million
March 31, 2026 47.5 million
Dec. 31, 2025 47.2 million
Sept. 30, 2025 46.2 million

CV Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 - 5.3 million 2.2 million 1.9 million
March 31, 2026 48000 4.4 million 1.9 million 2.1 million
Dec. 31, 2025 8000 8.8 million 1.7 million 1.9 million
Sept. 30, 2025 12000 6.1 million 2.1 million 1.8 million

CV Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 3.6 million 1.8 million
March 31, 2026 2.8 million 1.5 million
Dec. 31, 2025 3.9 million 2.0 million
Sept. 30, 2025 3.5 million 1.6 million

CV

Price: $5.95

52 week price:
3.43
15.37

Earnings Per Share: -1.06 USD

Exchange: NGM

Sector: Healthcare

Industry: Medical Devices

Market Capitalization: 307.8 million

Links: